BG102709A - Антиглюкокортикоидно лекарствено средство - Google Patents

Антиглюкокортикоидно лекарствено средство

Info

Publication number
BG102709A
BG102709A BG102709A BG10270998A BG102709A BG 102709 A BG102709 A BG 102709A BG 102709 A BG102709 A BG 102709A BG 10270998 A BG10270998 A BG 10270998A BG 102709 A BG102709 A BG 102709A
Authority
BG
Bulgaria
Prior art keywords
antiglucocorticoid
cells
chains
medicamentous
chain
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
BG102709A
Other languages
English (en)
Inventor
Original Assignee
Бурлаков Сергей
Генкин Дмитрий
Сурков Кирилл
Тец Виктор
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Бурлаков Сергей, Генкин Дмитрий, Сурков Кирилл, Тец Виктор filed Critical Бурлаков Сергей
Publication of BG102709A publication Critical patent/BG102709A/bg
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
    • A61P5/44—Glucocorticosteroids; Drugs increasing or potentiating the activity of glucocorticosteroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Abstract

(54) АНТИГЛЮКОКОРТИКОИДНО ЛЕКАРСТВЕНО СРЕДСТВО@(57) Средството намира приложение в хуманната и ветеринарна медицина. То представлява антиглю-кокортикоиден лекарствен препарат с нестероидна природа, сниска токсичност и висока ефикасност за регулиранечувствителността на клетките на мле-копитаещите към действието на глюкокортикоид-ните хормони. С цел селективно подтискане действието на глюкокортикоидните хормони върху клетвите на млекопитаещите сеизползва феромон от насекоми с нестероидна природа или негов синтетичен аналог или производно, представляващо дъл-говерижен ненаситен алифатен алкохол, алдехид или естер. Дължината на линейната въглеродна верига на всеки от посочените елементи е в границите от 10 до 21 атома. За увеличаване на терапевтичния ефект се използват два или повече феромона и/или техните синтетични аналози и производни, подбрани съгласно принципа на съществена разлика вхидрофобността, пропорционална на дължините на алифатните въглеводородни вериги. Разликата между дължините на веригите трябва да бъде не по-малка от пет.
BG102709A 1996-01-31 1998-08-20 Антиглюкокортикоидно лекарствено средство Pending BG102709A (bg)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
RU96101194/14A RU2125446C1 (ru) 1996-01-31 1996-01-31 Антиглюкокортикоидное лекарственное средство
PCT/RU1996/000028 WO1997027845A1 (fr) 1996-01-31 1996-02-01 Medicament a base d'anti-glucocorticoide

Publications (1)

Publication Number Publication Date
BG102709A true BG102709A (bg) 1999-06-30

Family

ID=20175968

Family Applications (1)

Application Number Title Priority Date Filing Date
BG102709A Pending BG102709A (bg) 1996-01-31 1998-08-20 Антиглюкокортикоидно лекарствено средство

Country Status (24)

Country Link
US (1) US5965623A (bg)
EP (1) EP0896819A4 (bg)
JP (1) JPH11504946A (bg)
KR (1) KR100347862B1 (bg)
CN (1) CN1213964A (bg)
AU (1) AU710479B2 (bg)
BG (1) BG102709A (bg)
BR (1) BR9612470A (bg)
CA (1) CA2244985A1 (bg)
CZ (1) CZ160598A3 (bg)
EE (1) EE9800209A (bg)
GE (1) GEP20001955B (bg)
HU (1) HUP9900504A2 (bg)
LT (1) LT4441B (bg)
LV (1) LV12177B (bg)
MD (1) MD1430B1 (bg)
MX (1) MX9806182A (bg)
NO (1) NO983508D0 (bg)
PL (1) PL187564B1 (bg)
RU (1) RU2125446C1 (bg)
SI (1) SI9620053A (bg)
SK (1) SK65598A3 (bg)
UA (1) UA48212C2 (bg)
WO (1) WO1997027845A1 (bg)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001039766A2 (en) * 1999-12-01 2001-06-07 Alydar Pharmaceuticals Ltd. Screening invertebrate pheromones for therapeutic activity
US6548706B2 (en) * 1999-12-23 2003-04-15 Aerojet Fine Chemicals Llc Preparation of 2S,3S-N-isobutyl-N-(2-hydroxy-3-amino-4-phenylbutyl) -p-nitrobenzenesulfonylamide hydrochloride and other derivatives of 2-hydroxy-1,3-diamines
EP1409656A4 (en) * 2001-03-12 2005-01-12 Darley Pharmaceuticals Ltd SCREENING OF PHEROMONAL COMPOUNDS OF NON-STEROID AND NON-PEPTIDE INVERTEBRATE HAVING ACTIVITY MODULATING MITOGEN-ACTIVATED PROTEIN KINASE
US6806293B1 (en) 2001-03-12 2004-10-19 Darley Pharmaceuticals Ltd Use of pheromone compounds having MAP kinase modulating activity
WO2003092614A2 (en) * 2002-05-02 2003-11-13 Hickle Randall S Lipid removal from the body
US6752649B2 (en) * 2002-11-07 2004-06-22 Xentris, Llc Illuminated indicia power supply apparatus and method of manufacture
DE10335845B4 (de) * 2003-05-09 2006-08-31 Müller, Martina, Dr.med. Pheromone als Antikrebsmittel
US20110195501A1 (en) * 2008-08-06 2011-08-11 Pangu Gautam D Ultrasonically induced release from polymer vesicles

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US161926A (en) 1875-04-13 Improvement in ink-wells
US2900756A (en) * 1958-12-09 1959-08-25 Jacobson Martin Attractants for the gypsy moth
EP0149847A3 (en) * 1983-12-26 1989-11-08 Eisai Co., Ltd. Therapeutic and preventive agent containing dolichol
JPH0759504B2 (ja) * 1986-01-23 1995-06-28 エーザイ株式会社 ポリプレニルアルコ−ル含有注射剤
US5019569A (en) * 1986-11-03 1991-05-28 Ortho Pharmaceutical Corporation Reversal of glucocorticoid-induced skin atrophy
US4740627A (en) * 1987-05-21 1988-04-26 Phillips Petroleum Company Synthesis of E,Z-11-tetradecen-1-al
ATE80313T1 (de) 1988-02-29 1992-09-15 Pfizer Mittel zur erhoehung des transdermalen penetrationsflusses.
US5190978A (en) * 1989-09-29 1993-03-02 Dai-Ichi Kogyo Seiyaku Co. Ltd. Carcinostatic compositions and methods

Also Published As

Publication number Publication date
GEP20001955B (en) 2000-03-05
PL322596A1 (en) 1998-02-02
EP0896819A4 (en) 2001-11-07
LV12177B (lv) 1999-06-20
UA48212C2 (uk) 2002-08-15
CN1213964A (zh) 1999-04-14
LT98054A (en) 1998-10-26
LV12177A (lv) 1998-12-20
CA2244985A1 (en) 1997-08-07
MX9806182A (es) 1998-10-31
WO1997027845A1 (fr) 1997-08-07
PL187564B1 (pl) 2004-08-31
BR9612470A (pt) 1999-07-13
CZ160598A3 (cs) 1998-08-12
HUP9900504A2 (en) 1999-09-28
AU710479B2 (en) 1999-09-23
AU4636396A (en) 1997-08-22
NO983508L (no) 1998-07-30
EE9800209A (et) 1998-12-15
SK65598A3 (en) 1998-09-09
MD1430B1 (ro) 2000-03-31
KR100347862B1 (ko) 2003-01-24
JPH11504946A (ja) 1999-05-11
US5965623A (en) 1999-10-12
EP0896819A1 (en) 1999-02-17
SI9620053A (sl) 1998-04-30
KR19990076946A (ko) 1999-10-25
NO983508D0 (no) 1998-07-30
LT4441B (lt) 1999-01-25
RU2125446C1 (ru) 1999-01-27

Similar Documents

Publication Publication Date Title
IT1256450B (it) Esteri nitrici con attivita' farmacologica e procedimento per la loro preparazione
MY110217A (en) Use of l-deprenyl for retarding deterioration due to aging in dogs
LV11279A (lv) Farmaceitiska kompozicija kas satur nervu augsanas faktoru
MY103518A (en) Steroid 5- -reductase inhibitors
ATE66808T1 (de) Zellstimulierendes mittel.
ATE5508T1 (de) Praeparate zur parenteralen verabreichung fettloeslicher wirkstoffe.
BG102709A (bg) Антиглюкокортикоидно лекарствено средство
AU1599092A (en) Reduction of ultra-violet photodamage with triesters of citric acid
ES2051678T1 (es) Derivados de 5-oxo-l-prolina y uso farmaceutico de los mismos.
SG139553A1 (en) 7-substituted-hept-6-enoic and -heptanoic acids and derivatives thereof
FI865227A0 (fi) Foerfarande foer framstaellning av ett depot-preparat.
SE9602280D0 (sv) Immunstimulerande lipidformulering
AU5104198A (en) Use of conjugated linoleic acid to enhance natural killer lymphocyte function
HUT68008A (en) Nucleosid and nucleosid-analogue derivatives and pharmaceutical preparations containing them
ES2120962T3 (es) Composicion antivirica.
ES2002083A6 (es) Un metodo para preparar derivados de piroglutamida
ES2095846T3 (es) Composicion estable y liofilizada de un ester/eter de polihematoporfirina.
EP0852144A3 (en) Enhancing keratinocyte migration and proliferation
IE772666L (en) Pharmaceutical composition
RU94045849A (ru) Устройство силовой передачи для бустера
Driedger et al. Non‐phorbol mouse skin tumor promoters do not mimic phorbol myristate acetate in its effects on chick embryo fibroblasts
DE3871081D1 (de) Testpflaster zum nachweisen einer kontaktallergie.
EP0751217A3 (en) Enhancing keratinocyte migration with clostridiopeptidase-A-collagenase
DE69322252T2 (de) Formulierung und verwendung von carotenoiden in der krebsbehandlung
INOUE Studies on deiodination occurring during pancreatin digestion of thyroid homogenates and its prevention by methimazole